Holly Hake Harris

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

Andrew Blauvelt, Kim Papp, Alice B. Gottlieb et al. · British Journal of Dermatology · 2019 · 172 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +15

Sustainable rates of sebum secretion in acne patients and matched normal control subjects

Holly Hake Harris, Donald T. Downing, Mary Ellen Stewart et al. · Journal of the American Academy of Dermatology · 1983 · 114 citations

Life Sciences, Dermatology, Immunology +14

Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis

Amy S. Paller, Marieke M.B. Seyger, Gabriel A. Magariños et al. · JAMA Dermatology · 2022 · 43 citations · Full text

Medicine, Dermatology, Pediatrics +13

Intrauterine herpes simplex infection resembling mechanobullous disease in a newborn infant

Holly Hake Harris, Elliott Foucar, Richard D. Andersen et al. · Journal of the American Academy of Dermatology · 1986 · 41 citations

Medicine, Infectious Diseases, Pediatrics +14